Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹2,668 Cr₹3,210 Cr₹3,019 Cr₹2,965 Cr₹3,408 Cr

What is the latest Total Current Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of EMCURE PHARMACEUTICALS is ₹2,668 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹2,668 Cr
Mar2024₹3,210 Cr
Mar2023₹3,019 Cr
Mar2022₹2,965 Cr
Mar2021₹3,408 Cr

How is Total Current Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2025 ₹2,668 Cr
-16.89
Mar2024 ₹3,210 Cr
6.34
Mar2023 ₹3,019 Cr
1.83
Mar2022 ₹2,965 Cr
-13.01
Mar2021 ₹3,408 Cr -

Compare Total Current Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹35,699.6 Cr 6.1% 10.8% 38.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,792.0 Cr 1.4% 1.2% 13.8% Stock Analytics
DIVIS LABORATORIES ₹178,152.0 Cr -0.5% -0.6% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,915.0 Cr 2.1% 1.5% 42.2% Stock Analytics
CIPLA ₹116,354.0 Cr 6.4% 1.6% -3.1% Stock Analytics
DR REDDYS LABORATORIES ₹112,681.0 Cr 6.2% 1.6% 0.2% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

6.1%

10.8%

38.8%

SENSEX

-0.4%

0.8%

-5.3%


You may also like the below Video Courses